Serveur d'exploration sur la télématique

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Long-term low-dose erythromycin in patients with unexplained chronic cough: a double-blind placebo controlled trial

Identifieur interne : 000C18 ( Main/Exploration ); précédent : 000C17; suivant : 000C19

Long-term low-dose erythromycin in patients with unexplained chronic cough: a double-blind placebo controlled trial

Auteurs : Nadia Yousaf [Royaume-Uni] ; William Monteiro [Royaume-Uni] ; Debbie Parker [Royaume-Uni] ; Sergio Matos [Portugal] ; Surinder Birring [Royaume-Uni] ; Ian D. Pavord [Royaume-Uni]

Source :

RBID : ISTEX:F4CA783D053064BB16E5007BFA5219761CEA769D

Abstract

Aims Unexplained chronic cough is a common condition with no satisfactory treatments. Previous work has suggested that cough may be linked to neutrophilic airway inflammation. This study tested the hypothesis that long-term low-dose erythromycin reduces the induced sputum neutrophil count and 24 h cough frequency in patients with unexplained chronic cough. Methods 30 patients with an unexplained chronic cough lasting more than 8 weeks were randomly assigned to take 250 mg erythromycin once daily (n=15) or placebo (n=15) for 12 weeks in a double-blind parallel group study. Cough frequency, cough reflex sensitivity and cough severity were assessed at baseline, 6, 12 and 24 weeks. The primary outcome measure was change in 24 h cough frequency at 12 weeks. Results There was no difference in the change in cough frequency between the erythromycin and placebo groups at 12 weeks (mean difference in fold change 1.1; 95% CI 0.7 to 1.5; p=0.585) or at other times. There was a statistically significant between-treatment difference in the change in sputum neutrophils at 12 weeks (−10.2% vs +6.6% with erythromycin and placebo; mean difference 16.8%; 95% CI 1.6 to 32.1; p=0.03) but not at other times. There was no difference in the change in other measures of cough between treatments. Conclusions Treatment with low-dose erythromycin for 12 weeks reduces the induced sputum neutrophil count but not cough frequency or severity in patients with unexplained chronic cough.

Url:
DOI: 10.1136/thx.2010.142711


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>Long-term low-dose erythromycin in patients with unexplained chronic cough: a double-blind placebo controlled trial</title>
<author>
<name sortKey="Yousaf, Nadia" sort="Yousaf, Nadia" uniqKey="Yousaf N" first="Nadia" last="Yousaf">Nadia Yousaf</name>
</author>
<author>
<name sortKey="Monteiro, William" sort="Monteiro, William" uniqKey="Monteiro W" first="William" last="Monteiro">William Monteiro</name>
</author>
<author>
<name sortKey="Parker, Debbie" sort="Parker, Debbie" uniqKey="Parker D" first="Debbie" last="Parker">Debbie Parker</name>
</author>
<author>
<name sortKey="Matos, Sergio" sort="Matos, Sergio" uniqKey="Matos S" first="Sergio" last="Matos">Sergio Matos</name>
</author>
<author>
<name sortKey="Birring, Surinder" sort="Birring, Surinder" uniqKey="Birring S" first="Surinder" last="Birring">Surinder Birring</name>
</author>
<author>
<name sortKey="Pavord, Ian D" sort="Pavord, Ian D" uniqKey="Pavord I" first="Ian D" last="Pavord">Ian D. Pavord</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:F4CA783D053064BB16E5007BFA5219761CEA769D</idno>
<date when="2010" year="2010">2010</date>
<idno type="doi">10.1136/thx.2010.142711</idno>
<idno type="url">https://api.istex.fr/document/F4CA783D053064BB16E5007BFA5219761CEA769D/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000006</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000006</idno>
<idno type="wicri:Area/Istex/Curation">000006</idno>
<idno type="wicri:Area/Istex/Checkpoint">000438</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000438</idno>
<idno type="wicri:doubleKey">0040-6376:2010:Yousaf N:long:term:low</idno>
<idno type="wicri:Area/Main/Merge">000C20</idno>
<idno type="wicri:Area/Main/Curation">000C18</idno>
<idno type="wicri:Area/Main/Exploration">000C18</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a">Long-term low-dose erythromycin in patients with unexplained chronic cough: a double-blind placebo controlled trial</title>
<author>
<name sortKey="Yousaf, Nadia" sort="Yousaf, Nadia" uniqKey="Yousaf N" first="Nadia" last="Yousaf">Nadia Yousaf</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Institute for Lung Health, Glenfield Hospital, University Hospitals of Leicester NHS Trust, Leicester</wicri:regionArea>
<wicri:noRegion>Leicester</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Monteiro, William" sort="Monteiro, William" uniqKey="Monteiro W" first="William" last="Monteiro">William Monteiro</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Institute for Lung Health, Glenfield Hospital, University Hospitals of Leicester NHS Trust, Leicester</wicri:regionArea>
<wicri:noRegion>Leicester</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Parker, Debbie" sort="Parker, Debbie" uniqKey="Parker D" first="Debbie" last="Parker">Debbie Parker</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Institute for Lung Health, Glenfield Hospital, University Hospitals of Leicester NHS Trust, Leicester</wicri:regionArea>
<wicri:noRegion>Leicester</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Matos, Sergio" sort="Matos, Sergio" uniqKey="Matos S" first="Sergio" last="Matos">Sergio Matos</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Portugal</country>
<wicri:regionArea>Institute of Electronics and Telematics Engineering (IEETA), University of Aveiro, Aveiro</wicri:regionArea>
<wicri:noRegion>Aveiro</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Birring, Surinder" sort="Birring, Surinder" uniqKey="Birring S" first="Surinder" last="Birring">Surinder Birring</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Kings College Hospital, Denmark Hill, London</wicri:regionArea>
<placeName>
<settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Pavord, Ian D" sort="Pavord, Ian D" uniqKey="Pavord I" first="Ian D" last="Pavord">Ian D. Pavord</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Institute for Lung Health, Glenfield Hospital, University Hospitals of Leicester NHS Trust, Leicester</wicri:regionArea>
<wicri:noRegion>Leicester</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<country wicri:rule="url">Royaume-Uni</country>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Thorax</title>
<title level="j" type="abbrev">Thorax</title>
<idno type="ISSN">0040-6376</idno>
<idno type="eISSN">1468-3296</idno>
<imprint>
<publisher>BMJ Publishing Group Ltd and British Thoracic Society</publisher>
<date type="published" when="2010-12">2010-12</date>
<biblScope unit="volume">65</biblScope>
<biblScope unit="issue">12</biblScope>
<biblScope unit="page" from="1107">1107</biblScope>
</imprint>
<idno type="ISSN">0040-6376</idno>
</series>
<idno type="istex">F4CA783D053064BB16E5007BFA5219761CEA769D</idno>
<idno type="DOI">10.1136/thx.2010.142711</idno>
<idno type="href">thoraxjnl-65-1107.pdf</idno>
<idno type="ArticleID">thoraxjnl142711</idno>
<idno type="PMID">20965928</idno>
<idno type="local">thoraxjnl;65/12/1107</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0040-6376</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract">Aims Unexplained chronic cough is a common condition with no satisfactory treatments. Previous work has suggested that cough may be linked to neutrophilic airway inflammation. This study tested the hypothesis that long-term low-dose erythromycin reduces the induced sputum neutrophil count and 24 h cough frequency in patients with unexplained chronic cough. Methods 30 patients with an unexplained chronic cough lasting more than 8 weeks were randomly assigned to take 250 mg erythromycin once daily (n=15) or placebo (n=15) for 12 weeks in a double-blind parallel group study. Cough frequency, cough reflex sensitivity and cough severity were assessed at baseline, 6, 12 and 24 weeks. The primary outcome measure was change in 24 h cough frequency at 12 weeks. Results There was no difference in the change in cough frequency between the erythromycin and placebo groups at 12 weeks (mean difference in fold change 1.1; 95% CI 0.7 to 1.5; p=0.585) or at other times. There was a statistically significant between-treatment difference in the change in sputum neutrophils at 12 weeks (−10.2% vs +6.6% with erythromycin and placebo; mean difference 16.8%; 95% CI 1.6 to 32.1; p=0.03) but not at other times. There was no difference in the change in other measures of cough between treatments. Conclusions Treatment with low-dose erythromycin for 12 weeks reduces the induced sputum neutrophil count but not cough frequency or severity in patients with unexplained chronic cough.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Portugal</li>
<li>Royaume-Uni</li>
</country>
<region>
<li>Angleterre</li>
<li>Grand Londres</li>
</region>
<settlement>
<li>Londres</li>
</settlement>
</list>
<tree>
<country name="Royaume-Uni">
<noRegion>
<name sortKey="Yousaf, Nadia" sort="Yousaf, Nadia" uniqKey="Yousaf N" first="Nadia" last="Yousaf">Nadia Yousaf</name>
</noRegion>
<name sortKey="Birring, Surinder" sort="Birring, Surinder" uniqKey="Birring S" first="Surinder" last="Birring">Surinder Birring</name>
<name sortKey="Monteiro, William" sort="Monteiro, William" uniqKey="Monteiro W" first="William" last="Monteiro">William Monteiro</name>
<name sortKey="Parker, Debbie" sort="Parker, Debbie" uniqKey="Parker D" first="Debbie" last="Parker">Debbie Parker</name>
<name sortKey="Pavord, Ian D" sort="Pavord, Ian D" uniqKey="Pavord I" first="Ian D" last="Pavord">Ian D. Pavord</name>
<name sortKey="Pavord, Ian D" sort="Pavord, Ian D" uniqKey="Pavord I" first="Ian D" last="Pavord">Ian D. Pavord</name>
</country>
<country name="Portugal">
<noRegion>
<name sortKey="Matos, Sergio" sort="Matos, Sergio" uniqKey="Matos S" first="Sergio" last="Matos">Sergio Matos</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Ticri/CIDE/explor/TelematiV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000C18 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000C18 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Ticri/CIDE
   |area=    TelematiV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:F4CA783D053064BB16E5007BFA5219761CEA769D
   |texte=   Long-term low-dose erythromycin in patients with unexplained chronic cough: a double-blind placebo controlled trial
}}

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Thu Nov 2 16:09:04 2017. Site generation: Sun Mar 10 16:42:28 2024